胰腺导管腺癌（PDAC）是最常见也是最致命的胰腺癌类型。大多数治疗策略都集中于阻断一种频繁突变的癌症基因，即KRAS。虽然这种方法在某些情况下有效，但许多PDAC肿瘤最终会逃避这些疗法。研究人员认为，联合使用针对其他分子靶点的疗法，有朝一日可能帮助医生克服这种耐药性。

New York State is giving $15 million for an expansion of Cold Spring Harbor Laboratory’s Pancreatic Cancer Center of Excellence. This funding, though Empire State Development, is designated for the ...

Her findings led to breakthroughs in the treatment of cancer and in the understanding of the mechanics of evolution. By Clay Risen Because much cancer research and clinical trials have been based on ...

Researchers at Cold Spring Harbor Laboratory have discovered a way to target proteins in human cells that lead to pancreatic tumors, findings that show promise toward early treatment and possible ...

New research from Cold Spring Harbor Labs shows that a compound related to vitamin K slowed the progression of prostate cancer in lab mice, offering a path for further study into one of the most ...

Long Island research organization Cold Spring Harbor Laboratory scored $15 million from the state to build a pancreatic cancer research center, Gov. Kathy Hochul announced Saturday. The Nassau County ...

Cold Spring Harbor Laboratory’s Genome Research Center in Woodbury purchased an advanced preclinical X-ray radiotherapy system to treat various cancers with funding that included a $250,000 state ...

Cold Spring Harbor Laboratory (SCHL) and Northwell Health have extended a strategic affiliation that aims to provide cancer patients with greater access to personalized healthcare. The alliance is ...

Cold Spring Harbor Laboratory's advanced mass spectrometry method enhances sensitivity, facilitating better drug target ...